| OPTImal Management of Antithrombotic Agents: OPTIMA-5 (NCT04116931) | The First Affiliated Hospital with Nanjing Medical University | 2020-06-22 |
| Implementing Precision Medicine Approaches to Guide Anti-platelet Selection (NCT04090281) | University of Southern California | 2020-03-13 |
| Prasugrel Switching Study in Patients With Acute Coronary Syndrome (ACS) Who Underwent Percutaneous Coronary Intervention (PCI) (NCT03672097) | Daiichi Sankyo Taiwan Ltd., a Daiichi Sankyo Company | 2018-10-16 |
| VITROS Immunodiagnostic Products hs Troponin I (NCT03581578) | Ortho-Clinical Diagnostics, Inc. | 2018-06-07 |
| Optimal Antithrombotic Therapy for ACS Patients Concomitant With AF and Implanted With New-generation DES (OPTIMA-3, 4) (NCT03234114) | The First Affiliated Hospital with Nanjing Medical University | 2018-02-03 |
| The Effect of IV Cangrelor and Oral Ticagrelor Study (NCT02733341) | The Royal Wolverhampton Hospitals NHS Trust | 2016-07-21 |
| Evaluation on the Safety of Ticagrelor Among Chinese ACS Patients (NCT02430493) | AstraZeneca | 2015-05-28 |
| EndoTic - Endothelium and Ticagrelor (NCT02244710) | Fundación Investigación Sanitaria en León | 2015-03-01 |
| Effects of Oxygen Treatment on Mechanisms Involved in Ischemia-reperfusion Injury: A Pilot Study in Healthy Volunteers (NCT02286544) | Karolinska Institutet | 2014-10-01 |
| Determination of the Role of Oxygen in Suspected Acute Myocardial Infarction by Biomarkers (NCT02290080) | Karolinska Institutet | 2014-10-01 |
| Real Life Long-term Adherence to Ticagrelor After PCI for Acute Coronary Syndromes (NCT02265068) | IHF GmbH - Institut für Herzinfarktforschung | 2014-08-01 |
| Effect of Perioperative Clopidogrel Responsiveness on Ischemic Outcome in Patients With Acute Coronary Syndrome Undergoing Off-pump Coronary Artery Bypass Surgery (NCT02184884) | Yonsei University | 2014-07-01 |
| PROSPECT II & PROSPECT ABSORB - an Integrated Natural History Study and Randomized Trial. (NCT02171065) | Uppsala University | 2014-06-01 |
| Prospective, Randomized Trial of Ticagrelor Versus Prasugrel in Patients With Acute Coronary Syndrome (NCT01944800) | Deutsches Herzzentrum Muenchen | 2013-09-15 |
| Optimum Troponin Cutoffs for ACS in the ED (NCT01994577) | Canadian Institutes of Health Research (CIHR) | 2013-05-01 |
| Study of Vascular Healing With the Combo Stent Versus the Everolimus Eluting Stent in ACS Patients by Means of OCT (NCT01405287) | OrbusNeich | 2011-10-01 |
| Prasugrel Versus High Dose Clopidogrel in Clopidogrel Resistant Patients Post Percutaneous Coronary Intervention (PCI). (NCT01109784) | University of Patras | 2010-04-01 |
| A Study Assessing the REG1 Anticoagulation System Compared Heparin in Subjects With Acute Coronary Syndrome (NCT00932100) | Regado Biosciences, Inc. | 2009-07-01 |
| Maintenance of Platelet Inhibition With Cangrelor (NCT00767507) | The Medicines Company | 2008-10-01 |
| Assessment of Endothelial Vasomotricity After Treatment by Nicotinic Acid in Acute Coronary Syndrome (NCT00855257) | French Cardiology Society | 2007-06-01 |
| Myeloperoxidase and Multi-Markers In the Diagnosis of Diagnoses of Acute Coronary Syndrome (MIDAS) - Sample Procurement (NCT00415948) | Abbott RDx Cardiometabolic | 2006-12-01 |
| Improving Medication Adherence Through Graphically Enhanced Interventions in Acute Coronary Syndromes (NCT00399880) | Vanderbilt University Medical Center | 2006-11-01 |
| Safety Study of Apixaban in Recent Acute Coronary Syndrome (NCT00313300) | Bristol-Myers Squibb | 2006-05-01 |
| A Trial of Inflammatory Markers, Depressive Symptoms, and Heart Disease (NCT00208117) | New York State Psychiatric Institute | 2005-04-01 |
| Essential Hypotension and Allostasis Registry (NCT02018497) | CES University | 1995-01-01 |